Biotech
BioPharma & Lifesciences Connected Live
“The central theme of this event is to hear directly from industry leaders and stakeholders who are willing to share challenges and solutions in...
Inspiring Leaders | Christian Joergensen
Christian Joergensen has been a CEO and member of executive management groups in several international high-performance companies. He has also been Chairman of the...
Embracing Change in the UK Biotech Sector – Insights from BioTrinity 2022
BioTrinity 2022 – The European Biopartnering and Investment Conference organised by OBN – took place 26-27 April 2022 in London. At this event, I...
The future of pharma working practices
The COVID-19 pandemic has led to fundamental changes in the way we work. The sudden shift to remote working has created an unprecedented opportunity...
Growing The RSA Group Talent Acquisition team | An interview with Christian Simon
What is your role at RSA and what motivates you to do what you do? I’m head of Talent Acquisition at The RSA Group....
Laura Warburton joins The RSA Group as Senior Consultant
The RSA Group, a leading Life Sciences Executive Search firm, is delighted to announce the appointment of new Senior Consultant Laura Warburton. In...
Recruit, Reward, Retain – training and upskilling in the life sciences
The RSA Group’s Eleanor Davies leads an expert panel discussion at Bio Integrates 2021 Hands up if you’re working in life sciences and want...
The RSA Group welcomes Heidi Kristiansen as Senior Researcher
The RSA Group, a leading Life Sciences Executive Search firm, is delighted to welcome Heidi Kristiansen to our growing Talent Acquisition Team as a...
Never has the life sciences sector been more important – it’s time for Boards to raise their game
In recent conversations with investors, availability of the right people to join biotech Boards has come up as a recurring theme and the prevailing...
Interim managers can help when international travel is restricted
As the world faces an unprecedented global shutdown amid the COVID-19 pandemic, for life sciences companies it’s in the interests of everyone, not least...
Could a different approach to head office teams drive better efficiency?
When done right, an interim manager can provide a cost-effective way to access the best talent to deliver a flexible solution, whilst transferring skills...
Attracting the Best Life Sciences Talent After Brexit
One of the reasons that the UK is a leader in life sciences has been its ability to attract, develop and retain a highly...
Launching your first medical product in Europe? How not to fail at the first step
So, you have your first product close to launch or are even on the market in the U.S. You’re planning to take it to...
Solving the life sciences talent puzzle in Asia
Living and working in the Asia-Pacific region for the past 7 years has given me a close-up view of the fast growth of its...
Swiss Biotech Day 2018: Themes, trends and thoughts
Last week I attended the Swiss BioTech Annual Meeting and their 20th Anniversary. The life sciences industry is facing a fascinating new era, and...
Finding talent for late stage neuroscience drug development
At a recent OBN/One Nucleus BioTuesday focusing on neurodegenerative diseases, I heard again the extent of the challenge faced by scientists wanting to develop...
Does the European Medicines Agency’s move to Amsterdam presage a brain drain from the UK?
Last week’s long-awaited announcement of the new home for the European Medicines Agency (EMA), from March 2019, puts the big question behind us but...
How hiring the best leaders maximizes biotech exit values
We’ve seen some major exits in the biotech market in 2017. Early in the year, in Switzerland alone, Actelion was sold to Johnson &...